LINSCOTT WALT ADDISON (Chief Business Officer) received a stock award from INDAPTUS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/29/2025ACC: 0001493152-25-029353
Officer· Chief Business Officer
Since Jul 2021
+54.42K
Net shares
Net buyer
$110.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
54.42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+54.42K
Price / share
$2.03
Trade value
$110.47K
% of position
1088420.0%
12/22/2025
5.00→54.43K
Total
Net shares
+54.42K
Net value
$110.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | A · Award | +54.42K | $2.03 | $110.47K | 1088420.0% | 5.00 | 54.43K |
| Total | +54.42K | $110.47K | ||||||
Derivative Transactions0
No derivative transactions reported